Less Time, Better Results.


Cytogenetics Database CytoD 1.0

Please enter your search karyotypes:    

Search Results:

Query: t(11;14)(q13;q32)

Search Results:

t(11;14)(q13;q32)     Cytogenetic studies in splenic lymphoma with villous lymphocytes. Br J Haematol. 1993 Nov;85(3):487-91.
t(11;14)(q13;q32)     Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies. Leuk Res. 2001 Feb;25(2):115-23.
t(11;14)(q13;q32)     Clonal evolution of chronic lymphocytic leukemia to acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1996 Feb;86(2):143-6.
t(11;14)(q13;q32)     TPA stimulation culture for improved detection of t(11;14)(q13;q32) in mantle cell lymphoma. Ann Genet. 2002 Jul-Sep;45(3):165-8.
t(11;14)(q13;q32)     Multiple myeloma and the translocation t(11;14)(q13;q32): a report on 13 cases. Br J Haematol. 1998 May;101(2):296-301.
t(11;14)(q13;q32)     Translocation (8;14)(q24;q32) as the sole cytogenetic abnormality in B-cell prolymphocytic leukemia. Cancer Genet Cytogenet. 2004 Apr 15;150(2):156-8.
t(11;14)(q13;q32)     Comment in: Am J Clin Pathol. 2001 Nov;116(5):781-2. Am J Clin Pathol. 2001 Apr;115(4):571-81.
t(11;14)(q13;q32)     A comparative analysis of FISH, RT-PCR, PCR, and immunohistochemistry for the diagnosis of mantle cell lymphomas. Mod Pathol. 2002 May;15(5):517-25.
t(11;14)(q13;q32)     Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus. Jpn J Cancer Res. 1994 Sep;85(9):918-26.
t(11;14)(q13;q32)     Establishment of CD7+ human myeloma sister cell lines, KMS-21-PE and KMS-21-BM, carrying t(11;14) and t(8;14). Leuk Lymphoma. 2001 Aug;42(4):761-74.
t(11;14)(q13;q32)     Distinct patterns of chromosome abnormalities characterize childhood non-Hodgkin's lymphoma. Br J Haematol. 1992 Jan;80(1):15-20.
t(11;14)(q13;q32)     Fluorescent in situ hybridization analysis of an atypical t(11;14)(q13;q32) without expression of the cyclin D1 gene. Leukemia. 1993 Nov;7(11):1924-7.
t(11;14)(q13;q32)     Rapid molecular cloning of rearrangements of the IGHJ locus using long-distance inverse polymerase chain reaction. Blood. 1997 Sep 15;90(6):2456-64.
t(11;14)(q13;q32)     BCL6 rearrangement in a patient with mantle cell lymphoma. Ann Hematol. 1997 May;74(5):247-50.
t(11;14)(q13;q32)     Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B-cell malignancies. Genes Chromosomes Cancer. 1993 Oct;8(2):80-7.
t(11;14)(q13;q32)     The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11;14)(q13;q32) chromosome abnormality from an aggressive nonsecretory plasma cell leukemia. Cancer. 1992 Sep 15;70(6):1528-35.
t(11;14)(q13;q32)     Cloning of the t(11;14)(q13;q32) translocation breakpoints from two human leukemia cell lines. Leukemia. 1991 Sep;5(9):733-7.
t(11;14)(q13;q32)     In situ hybridization detection of cyclin D1 mRNA in centrocytic/mantle cell lymphoma. Ann Oncol. 1995 Mar;6(3):297-9.
t(11;14)(q13;q32)     Cytogenetics in multiple myeloma: a multicenter study of 24 patients with t(11;14)(q13;q32) or its variant. Cancer Genet Cytogenet. 1998 Jul 15;104(2):133-8.
t(11;14)(q13;q32)     Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma. Int J Mol Med. 1999 Apr;3(4):373-9.
t(11;14)(q13;q32)     Leukemic mantle cell lymphoma: clinical and pathologic spectrum of twenty-three cases. Mod Pathol. 2001 Nov;14(11):1133-40.
t(11;14)(q13;q32)     Low prevalence of circulating t(11;14)(q13;q32)-positive cells in the peripheral blood of healthy individuals as detected by real-time quantitative PCR. Blood. 2004 Aug 1;104(3):904-5.
t(11;14)(q13;q32)     Non-Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone/intermediate lymphocytic lymphoma? Br J Haematol. 1991 Mar;77(3):346-53.
t(11;14)(q13;q32)     Involvement of the CCND1 gene in hairy cell leukemia. Ann Oncol. 1996 Mar;7(3):251-6.
t(11;14)(q13;q32)     Guess what: Chronic 13q14.3+/CD5-/CD23+ lymphocytic leukemia in blood and t(11;14)(q13;q32)+/CD5+/CD23- mantle cell lymphoma in lymph nodes! Cytometry. 2003 Jan;51B(1):41-4.
t(11;14)(q13;q32)     Overexpression of cyclin D1 in chronic lymphoproliferation with t(11; 14)(q13; q32) Int J Hematol. 1997 Dec;66(4):521-3.
t(11;14)(q13;q32)     Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas. Oncogene. 1989 Sep;4(9):1111-6.
t(11;14)(q13;q32)     p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood. 1995 Oct 15;86(8):2892-9.
t(11;14)(q13;q32)     Over-expression of cyclin D1 in chronic B-cell malignancies with abnormality of chromosome 11q13. Br J Haematol. 1995 Apr;89(4):798-804.
t(11;14)(q13;q32)     Non-multiple lymphomatous polyposis form of mantle cell lymphoma in the gastrointestinal tract. J Gastroenterol. 2004 Oct;39(10):995-1000.
t(11;14)(q13;q32)     Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B-cell lymphoma. Br J Haematol. 1997 Aug;98(2):446-9.
t(11;14)(q13;q32)     CD23 negative chronic lymphocytic leukemia of the tonsil: report of a case. J La State Med Soc. 2002 May-Jun;154(3):141-3.
t(11;14)(q13;q32)     Real-time 5'-->3' exonuclease-based PCR assay for detection of the t(11;14)(q13;q32). Am J Clin Pathol. 1999 Oct;112(4):524-30.
t(11;14)(q13;q32)     Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes. Hum Pathol. 2003 Oct;34(10):1030-4.
t(11;14)(q13;q32)     A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene. Blood. 1994 Aug 15;84(4):1226-31.
t(11;14)(q13;q32)     [Overexpression of PRAD1 gene in B-cell malignancy with t(11;14)(q13;q32) translocation] Nippon Rinsho. 1992 Jun;50(6):1374-9.
t(11;14)(q13;q32)     Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis. Blood. 2001 Oct 1;98(7):2266-8.
t(11;14)(q13;q32)     Establishment and characterization of a new mantle cell lymphoma cell line, Mino. Leuk Res. 2002 Sep;26(9):849-55.
t(11;14)(q13;q32)     From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. Hum Pathol. 2002 Jan;33(1):7-20.
t(11;14)(q13;q32)     Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation. Br J Haematol. 1995 Jun;90(2):409-16.
t(11;14)(q13;q32)     Bcl-1 gene rearrangements in B cell lymphoma. Leukemia. 1988 Jun;2(6):343-6.
t(11;14)(q13;q32)     Detection of cyclin D1 (bcl-1, PRAD1) overexpression by a simple competitive reverse transcription-polymerase chain reaction assay in t(11;14)(q13;q32)-bearing B-cell malignancies and/or mantle cell lymphoma. Blood. 1997 Feb 1;89(3):965-74.
t(11;14)(q13;q32)     Mantle cell lymphoma, in leukaemic phase with prominent splenomegaly. A report of eight cases with similar clinical presentation and aggressive outcome. Virchows Arch. 2000 Dec;437(6):591-8.
t(11;14)(q13;q32)     Cyclin D1 expression in mantle cell lymphoma is accompanied by downregulation of cyclin D3 and is not related to the proliferative activity. Blood. 1997 Oct 15;90(8):3154-9.
t(11;14)(q13;q32)     A plasma cell leukemia patient showing bialleic 14q translocations: t(2;14) and t(11;14). Acta Haematol. 1999;101(4):197-201.
t(11;14)(q13;q32)     Cytogenetic abnormalities in chronic lymphocytic leukemia. Folia Med (Plovdiv). 2000;42(3):5-10.
t(11;14)(q13;q32)     Overexpression of PRAD1 in a mantle zone lymphoma patient with a t(11;22)(q13;q11) translocation. Br J Haematol. 1993 Oct;85(2):427-9.
t(11;14)(q13;q32)     Cyclin D1/PRAD1/BCL-1 alternative transcript [B] protein product in B-lymphoid malignancies with t(11;14)(q13;q32) translocation. Int J Cancer. 1999 May 17;81(4):616-9.
t(11;14)(q13;q32)     Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing delta/lambda type immunoglobulin. Leuk Res. 2004 Aug;28(8):869-77.
t(11;14)(q13;q32)     Banded chromosomes versus fluorescence in situ hybridization in the diagnosis of mantle cell lymphoma: a lesson from three cases. Cancer Genet Cytogenet. 2002 Jul 15;136(2):108-12.
t(11;14)(q13;q32)     Clinical aspects of B-cell malignancy involving the BCL1/PRAD1 locus. Int J Hematol. 1994 Jun;59(4):281-96.
t(11;14)(q13;q32)     [Interphase FISH analysis on histologic sections of fixed tissues for t(11;14) (q13;q32) detection in mantle cell lymphoma and t(8;14)(q24;q32) in Burkitt's lymphoma] Ann Pathol. 2002 Apr;22(2):145-9.
t(11;14)(q13;q32)     Significance of cyclin D1 overexpression for the diagnosis of mantle cell lymphoma: a clinicopathologic comparison of cyclin D1-positive MCL and cyclin D1-negative MCL-like B-cell lymphoma. Blood. 2000 Apr 1;95(7):2253-61.
t(11;14)(q13;q32)     Chromosome 11q rearrangements in B non Hodgkin's lymphoma. Br J Haematol. 1992 Jun;81(2):212-7.
t(11;14)(q13;q32)     Insertion of the CCND1 gene into the IgH locus in a case of leukaemic small cell mantle lymphoma with normal chromosomes 11 and 14. J Clin Pathol. 2003 Oct;56(10):798-800.
t(11;14)(q13;q32)     Establishment and characterization of a mantle cell lymphoma cell line. Br J Haematol. 1998 Sep;102(5):1323-6.
t(11;14)(q13;q32)     Molecular breakpoints of t(11;14)(q13;q32) in multiple myeloma. Cancer Genet Cytogenet. 1995 Aug;83(1):25-7.
t(11;14)(q13;q32)     Mantle cell lymphoma: a lymphoproliferative disorder associated with aberrant function of the cell cycle. Leukemia. 1996 Jun;10 Suppl 2:s78-83.
t(11;14)(q13;q32)     Correlations between karyotype and cytologic findings in multiple myeloma. Leukemia. 1995 Dec;9(12):2119-22.
t(11;14)(q13;q32)     Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia. 1993 Sep;7(9):1437-40.
t(11;14)(q13;q32)     A new multiple myeloma cell line, MEF-1, possesses cyclin D1 overexpression and the p53 mutation. Cancer. 1999 Apr 15;85(8):1750-7.
t(11;14)(q13;q32)     Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-BM, were established from a patient, having the same chromosome marker, t(11;14)(q13;q32). Br J Haematol. 1989 Oct;73(2):199-204.
t(11;14)(q13;q32)     Molecular cytogenetic characterization of the mantle cell lymphoma cell line GRANTA-519. Cancer Genet Cytogenet. 2004 Sep;153(2):144-50.
t(11;14)(q13;q32)     Characterization of a candidate bcl-1 gene. Mol Cell Biol. 1991 Oct;11(10):4846-53.
t(11;14)(q13;q32)     B-prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia. Br J Haematol. 2004 May;125(3):330-6.
t(11;14)(q13;q32)     Frequent allelic loss of the BCL10 gene in lymphomas with the t(11;14)(q13;q32). Leukemia. 2001 Mar;15(3):474-5.
t(11;14)(q13;q32)     Molecular cytogenetic study of a mantle cell lymphoma with a complex translocation involving the CCND1 (11q13) region. Cancer Genet Cytogenet. 2004 Oct 1;154(1):67-71.
t(11;14)(q13;q32)     t(11;14)(q13;q32): chronic lymphocytic leukaemia or mantle cell leukaemia? Br J Haematol. 1996 Dec;95(3):572-3.
t(11;14)(q13;q32)     The ultrastructure of mantle cell lymphoma and other B-cell disorders with translocation t(11;14)(q13;q32). Br J Haematol. 1996 Aug;94(2):352-61.
t(11;14)(q13;q32)     Cytogenetic and interphase cytogenetic characterization of atypical chronic lymphocytic leukemia carrying BCL1 translocation. Cancer Res. 1997 Mar 15;57(6):1144-50.
t(11;14)(q13;q32)     Cytogenetic studies of composite lymphomas: monocytoid B-cell lymphoma and other B-cell non-Hodgkin's lymphomas. Hum Pathol. 1993 Oct;24(10):1086-94.
t(11;14)(q13;q32)     Break in the BCL1 locus is closely associated with intermediate lymphocytic lymphoma subtype. Genes Chromosomes Cancer. 1990 Sep;2(3):223-6.
t(11;14)(q13;q32)     The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study. Am J Clin Pathol. 2000 Jun;113(6):831-7.
t(11;14)(q13;q32)     Frequent amplification of the bcl-1 locus in poorly differentiated squamous cell carcinoma of the lung. The Lung Cancer Study Group. Oncogene. 1990 Sep;5(9):1343-8.
t(11;14)(q13;q32)     Cytogenetic studies on prolymphocytic leukemia. 1. B-cell prolymphocytic leukemia. Hematol Pathol. 1987;1(1):27-33.
t(11;14)(q13;q32)     Two new cell lines from B-prolymphocytic leukaemia: characterization by morphology, immunological markers, karyotype and Ig gene rearrangement. Int J Cancer. 1986 Oct 15;38(4):531-8.
t(11;14)(q13;q32)     Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: correlations between recurrent aberrations, histology, and exposure to cytotoxic treatment. Genes Chromosomes Cancer. 1991 May;3(3):189-201.
t(11;14)(q13;q32)     Detection of the bcl-1 rearrangement at the major translocation cluster in frozen and paraffin-embedded tissues of mantle cell lymphomas by polymerase chain reaction. Am J Clin Pathol. 1996 May;105(5):532-7.
t(11;14)(q13;q32)     BCL-1 rearrangements and p53 mutations in atypical chronic lymphocytic leukemia with t(11;14)(q13;q32). Haematologica. 2000 Sep;85(9):913-21.
t(11;14)(q13;q32)     Potential role for concurrent abnormalities of the cyclin D1, p16CDKN2 and p15CDKN2B genes in certain B cell non-Hodgkin's lymphomas. Functional studies in a cell line (Granta 519). Leukemia. 1997 Jan;11(1):64-72.
t(11;14)(q13;q32)     Molecular cloning of a t(11;14)(q13;q32) translocation breakpoint centromeric to the BCL1-MTC. Genes Chromosomes Cancer. 1994 Dec;11(4):246-55.
t(11;14)(q13;q32)     Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21q23). Blood. 1994 May 1;83(9):2611-8.
t(11;14)(q13;q32)     Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma. Br J Haematol. 2000 Sep;110(4):856-62.
t(11;14)(q13;q32)     Translocation 11;14 in newly diagnosed chronic myelogenous leukemia. Cancer Genet Cytogenet. 1995 May;81(1):24-7.
t(11;14)(q13;q32)     The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma. Cancer. 1989 Sep 15;64(6):1248-53.
t(11;14)(q13;q32)     Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma. Leukemia. 2004 Oct;18(10):1705-10.
t(11;14)(q13;q32)     Mantle cell lymphoma: improved diagnostics using a combined approach of immunohistochemistry and identification of t(11;14)(q13;q32) by polymerase chain reaction and fluorescence in situ hybridization. Virchows Arch. 2003 Jun;442(6):538-47. Epub 2003 May 01.
t(11;14)(q13;q32)     The use of "touchdown" polymerase chain reaction increases the sensitivity and specificity of t(11;14)(q13;q32) detection in patients with mantle cell lymphoma. Br J Haematol. 2003 Jun;121(6):952-3.
t(11;14)(q13;q32)     [Cytogenetics of malignant lymphomas] Verh Dtsch Ges Pathol. 1992;76:60-5.
t(11;14)(q13;q32)     Identification of two subgroups of mantle cell leukemia with distinct clinical and biological features. Hematol J. 2001;2(4):234-41.
t(11;14)(q13;q32)     Messenger RNA levels of five genes located at chromosome 11q13 in B-cell tumors with chromosome translocation t(11;14)(q13;q32). Cancer Res. 1994 Jan 15;54(2):377-9.
t(11;14)(q13;q32)     Inhibition of the proteasome induces cell cycle arrest and apoptosis in mantle cell lymphoma cells. Br J Haematol. 2003 Jul;122(2):260-8.
t(11;14)(q13;q32)     Detection of translocation t(11;14)(q13;q32) in mantle cell lymphoma by fluorescence in situ hybridization. Am J Pathol. 1999 May;154(5):1449-52.
t(11;14)(q13;q32)     Cyclin D1 and E2F-1 immunoreactivity in bone marrow biopsy specimens of multiple myeloma: relationship to proliferative activity, cytogenetic abnormalities and DNA ploidy. Br J Haematol. 2001 Mar;112(3):776-82.
t(11;14)(q13;q32)     Simultaneous presence of t(11;14) and a variant Burkitt's translocation in the terminal phase of a mantle cell lymphoma. Leukemia. 1996 Feb;10(2):346-50.
t(11;14)(q13;q32)     Translocation (11;14)(q13;q32) and preferential involvement of chromosomes 1, 2, 9, 13, and 17 in mantle cell lymphoma. Cancer Genet Cytogenet. 1999 May;111(1):92-8.
t(11;14)(q13;q32)     11q13 rearrangement in B cell chronic lymphocytic leukemia. Leuk Lymphoma. 1997 May;25(5-6):539-43.
t(11;14)(q13;q32)     Molecular methods for detecting t(11;14) translocations in mantle-cell lymphomas. Diagn Mol Pathol. 1998 Aug;7(4):209-14.
t(11;14)(q13;q32)     B-cell chronic lymphocytic leukaemia: clonal chromosome abnormalities and prognosis in 89 cases. Eur J Haematol. 1989 Nov;43(5):397-403.
t(11;14)(q13;q32)     Genomic organization and localization of the gene encoding human preprogalanin. Genomics. 1993 Dec;18(3):473-7.
t(11;14)(q13;q32)     Cytogenetic profile of lymphoma of follicle mantle lineage: correlation with clinicobiologic features. Blood. 1999 Feb 15;93(4):1372-80.
t(11;14)(q13;q32)     Non-Hodgkin's lymphomas of primary follicle/mantle zone origin. Leukemia. 1991;5 Suppl 1:26-9.
t(11;14)(q13;q32)     Rearrangement and overexpression of the BCL-1/PRAD-1 gene in intermediate lymphocytic lymphomas and in t(11q13)-bearing leukemias. Blood. 1993 Jun 1;81(11):3063-7.
t(11;14)(q13;q32)     Characterization of 4 mantle cell lymphoma cell lines. Arch Pathol Lab Med. 2003 Apr;127(4):424-31.
t(11;14)(q13;q32)     MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas. J Hum Genet. 2002;47(9):460-4.
t(11;14)(q13;q32)     Genetic analysis of splenic lymphoma with villous lymphocytes: a Groupe Français d'Hématologie Cellulaire (GFHC) study. Br J Haematol. 1998 Jun;101(4):712-21.
t(11;14)(q13;q32)     Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet. 1995 Jul 1;82(1):41-9.
t(11;14)(q13;q32)     Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). Blood. 2000 Apr 15;95(8):2691-8.
t(11;14)(q13;q32)     Leukaemic intermediate lymphocytic lymphomas: analysis of twelve cases diagnosed by morphology. Leuk Lymphoma. 1992 Nov;8(4-5):381-7.
t(11;14)(q13;q32)     Detection of chromosome 11 alterations in blood and bone marrow by interphase cytogenetics in mantle cell lymphoma. Br J Haematol. 1995 Mar;89(3):665-8.
t(11;14)(q13;q32)     Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. Oncogene. 1992 Jul;7(7):1401-6.
t(11;14)(q13;q32)     Overexpression of PRAD1/cyclin D1 in plasma cell leukemia with t(11;14)(q13;q32). Int J Hematol. 1997 Jul;66(1):111-5.
t(11;14)(q13;q32)     Biology and management of mantle cell lymphoma. Curr Opin Oncol. 2001 Sep;13(5):342-7.
t(11;14)(q13;q32)     Translocation t(11;14)(q13;q32) in chronic lymphoid disorders. Genes Chromosomes Cancer. 1992 Sep;5(2):158-65.
t(11;14)(q13;q32)     Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with the t(11;14)(q13;q32): role for a p53 exon 7 gene mutation. Br J Haematol. 1996 Feb;92(2):375-81.
t(11;14)(q13;q32)     Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. Blood. 2004 Oct 21; [Epub ahead of print]
t(11;14)(q13;q32)     Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels. Blood. 2004 Aug 15;104(4):1120-6. Epub 2004 Apr 13.
t(11;14)(q13;q32)     Translocation t(11;14)(q13;q32) is the hallmark of IgM, IgE, and nonsecretory multiple myeloma variants. Blood. 2003 Feb 15;101(4):1570-1. Epub 2002 Oct 03.
t(11;14)(q13;q32)     Differential tumorigenicity between Epstein-Barr virus genome-positive and genome-negative cell lines with t(11;14)(q13;q32) derived from mantle cell lymphoma. J Virol. 1996 Dec;70(12):9003-7.
t(11;14)(q13;q32)     Chromosome 11 translocation breakpoints at the PRAD1/cyclin D1 gene locus in centrocytic lymphoma. Leukemia. 1993 Feb;7(2):241-5.
t(11;14)(q13;q32)     Leukaemic non-Hodgkin's lymphomas with hyperdiploid cells and t(11;14)(q13;q32): a subtype of mantle cell lymphoma? Br J Haematol. 1995 May;90(1):77-84.
t(11;14)(q13;q32)     Comment in: J Clin Oncol. 1994 Apr;12(4):876-7. J Clin Oncol. 1993 Apr;11(4):802-111.
t(11;14)(q13;q32)     An additional breakpoint region in the BCL-1 locus associated with the t(11;14)(q13;q32) translocation of B-lymphocytic malignancy. Blood. 1989 Oct;74(5):1801-6.
t(11;14)(q13;q32)     Molecular mapping of the chromosome 11 breakpoint of t(11;17)(q13;q21) in a t(11;14)(q13;q32)-positive B non-Hodgkin's lymphoma. Genes Chromosomes Cancer. 1993 Dec;8(4):224-9.
t(11;14)(q13;q32)     Splenic lymphoma with villous lymphocytes: analysis of BCL-1 rearrangements and expression of the cyclin D1 gene. Blood. 1994 Jun 15;83(12):3664-71.
t(11;14)(q13;q32)     Mantle cell leukemia, prolymphocytoid type: a rarely described form. Leuk Lymphoma. 2001 May;41(5-6):683-7.
t(11;14)(q13;q32)     Der(16)t(1;16)(q10;p10) in multiple myeloma: a new non-random abnormality that is frequently associated with Burkitt's-type translocations. Leukemia. 1995 Feb;9(2):277-81.
t(11;14)(q13;q32)     The ATM gene in the pathogenesis of mantle-cell lymphoma. Ann Oncol. 2000;11 Suppl 1:127-30.
t(11;14)(q13;q32)     Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood. 2003 Jun 1;101(11):4569-75. Epub 2003 Feb 06.
t(11;14)(q13;q32)     Predictive role of interphase cytogenetics for survival of patients with multiple myeloma. J Clin Oncol. 2000 Feb;18(4):804-12.
t(11;14)(q13;q32)     Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis. Br J Haematol. 2002 May;117(2):427-35.
t(11;14)(q13;q32)     Detection of 11q13 rearrangements in hematologic neoplasias by double-color fluorescence in situ hybridization. Blood. 1996 Feb 15;87(4):1512-9.
t(11;14)(q13;q32)     Tumor-specific rearrangements of the immunoglobulin heavy-chain gene in B-cell non-Hodgkin's lymphoma detected by in situ hybridization. Blood. 1996 Jan 1;87(1):292-8.
t(11;14)(q13;q32)     Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation. Int J Oncol. 1999 Dec;15(6):1205-12.
t(11;14)(q13;q32)     Overexpression of the PRAD1 oncogene in a patient with multiple myeloma and t(11;14)(q13;q32). Acta Haematol. 1995;94(4):199-203.
t(11;14)(q13;q32)     Mantle cell lymphoma: a biological and therapeutic paradigm. Leuk Lymphoma. 2002 Apr;43(4):773-81.
t(11;14)(q13;q32)     Localization of the HST/FGFK gene with regard to 11q13 chromosomal breakpoint and fragile site. Genes Chromosomes Cancer. 1991 May;3(3):210-4.
t(11;14)(q13;q32)     [Translocation t(11;14) (q13;q32) in six patients with lymphoid malignancies of mature B-cell phenotype] Rinsho Ketsueki. 1994 Feb;35(2):107-13.
t(11;14)(q13;q32)     High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Res. 1998 Dec 15;58(24):5640-5.
t(11;14)(q13;q32)     Comment in: Blood. 1998 Oct 15;92(8):2987-9. Blood. 1997 Nov 15;90(10):4062-70.
t(11;14)(q13;q32)     Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features. Mod Pathol. 2002 Dec;15(12):1266-72.
t(11;14)(q13;q32)     Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas. Leukemia. 1998 Oct;12(10):1630-7.
t(11;14)(q13;q32)     Erratum in: Br J Haematol 2002 Mar;116(3):730. Br J Haematol. 2001 Sep;114(3):591-9.
t(11;14)(q13;q32)     Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD). Leukemia. 1999 Nov;13(11):1833-42.
t(11;14)(q13;q32)     Application of interphase cytogenetics for the detection of t(11;14)(q13;q32) in mantle cell lymphomas. Ann Oncol. 1998 May;9(5):519-26.
t(11;14)(q13;q32)     Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses. Genes Chromosomes Cancer. 2004 Nov 12; [Epub ahead of print]
t(11;14)(q13;q32)     Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results. Br J Haematol. 2003 Mar;120(6):944-52.
t(11;14)(q13;q32)     MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer. Int J Cancer. 2002 Dec 20;102(6):608-14.
t(11;14)(q13;q32)     Implication of cyclin D1 in malignant lymphoma. Crit Rev Oncog. 1996;7(3-4):191-203.
t(11;14)(q13;q32)     Overexpression of the PRAD1 oncogene in a patient with prolymphocytic leukemia with t(11;14)(q13;q32). Cancer Genet Cytogenet. 1995 Oct 1;84(1):69-72.
t(11;14)(q13;q32)     Molecular analysis of breaks in BCL-1 proto-oncogene in B-cell lymphomas with abnormalities of 11q13. Oncogene. 1989 Jul;4(7):929-34.
t(11;14)(q13;q32)     Significance of chromosomal markers in the diagnosis of mantle cell lymphoma (MCL). J Appl Genet. 2002;43(4):545-53.
t(11;14)(q13;q32)     Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients. Blood. 2002 May 15;99(10):3735-41.
t(11;14)(q13;q32)     Chromosome analyses in chronic lymphocytic leukemia and related B-cell neoplasms. Cancer Genet Cytogenet. 1991 Aug;55(1):49-56.
t(11;14)(q13;q32)     Both IGH translocations and chromosome 13q deletions are early events in monoclonal gammopathy of undetermined significance and do not evolve during transition to multiple myeloma. Leukemia. 2004 Nov;18(11):1879-82.
t(11;14)(q13;q32)     Multiple breakpoints within the BCL-1 locus in B-cell lymphoma: rearrangements of the cyclin D1 gene. Cancer Res. 1993 Sep 15;53(18):4148-52.
t(11;14)(q13;q32)     The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood. 1985 Aug;66(2):380-90.
t(11;14)(q13;q32)     Clinical significance of the translocation (11;14)(q13;q32) in multiple myeloma. Leuk Lymphoma. 1999 Nov;35(5-6):599-605.
t(11;14)(q13;q32)     Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma. Oncogene. 1995 May 4;10(9):1833-40.
t(11;14)(q13;q32)     Oncogene rearrangements in chronic B-cell leukemia. Blood. 1991 Apr 1;77(7):1560-4.
t(11;14)(q13;q32)     Characterization of a new non-Hodgkin's lymphoma cell line (NCEB-1) with a chromosomal (11:14) translocation [t(11:14)(q13;q32)] Blood. 1988 Dec;72(6):2026-30.
t(11;14)(q13;q32)     Cyclin D1 expression in patients with multiple myeloma. Hematol J. 2000;1(3):181-5.
t(11;14)(q13;q32)     Multiple chromosomal abnormalities in fulminant anaplastic myeloma. Clin Lab Haematol. 1999 Jun;21(3):207-10.
t(11;14)(q13;q32)     The gene that encodes the human CD20 (B1) differentiation antigen is located on chromosome 11 near the t(11;14)(q13;q32) translocation site. J Immunol. 1989 Apr 1;142(7):2555-9.
t(11;14)(q13;q32)     Comment in: Leukemia. 2003 Oct;17(10):1943-4. Leukemia. 2003 Oct;17(10):2032-5.
t(11;14)(q13;q32)     Chromosome abnormalities in malignant lymphoma in patients from Kurashiki: histological and immunophenotypic correlations. Cancer Res. 1990 May 1;50(9):2698-703.
t(11;14)(q13;q32)     Detection of the chromosomal translocation t(11;14) by polymerase chain reaction in mantle cell lymphomas. Blood. 1994 Apr 1;83(7):1871-5.
t(11;14)(q13;q32)     Visualization of mono-allelic chromosomal aberrations 3' and 5' of the cyclin D1 gene in mantle cell lymphoma using DNA fiber fluorescence in situ hybridization. Oncogene. 1997 Sep 25;15(13):1599-603.
t(11;14)(q13;q32)     Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immunol. 1992;10:785-807.
t(11;14)(q13;q32)     Detection of t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia. Genes Chromosomes Cancer. 1998 Oct;23(2):175-82.
t(11;14)(q13;q32)     Comment in: Cancer Res. 2003 Apr 1;63(7):1722-3. Cancer Res. 2001 Feb 15;61(4):1629-36.
t(11;14)(q13;q32)     Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma. Cancer Res. 1997 Oct 15;57(20):4608-14.
t(11;14)(q13;q32)     Characterization of t(11;14) translocation in mantle cell lymphoma by fluorescent in situ hybridization. Oncogene. 1996 Aug 15;13(4):797-802.
t(11;14)(q13;q32)     Karyotype in multiple myeloma and plasma cell leukaemia. Eur J Cancer. 1993;29A(9):1269-73.
t(11;14)(q13;q32)     Is a duplication of 14q32 a new recurrent chromosomal alteration in B-cell non-Hodgkin lymphoma? Cancer Genet Cytogenet. 1999 Aug;113(1):19-24.
t(11;14)(q13;q32)     14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome. Cancer Res. 1999 Sep 15;59(18):4546-50.
t(11;14)(q13;q32)     Comparison of chromosome analysis and BCL-1 rearrangement in a series of patients with multiple myeloma. Br J Haematol. 1992 May;81(1):58-61.
t(11;14)(q13;q32)     Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood. 1996 Aug 15;88(4):1177-82.
t(11;14)(q13;q32)     Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections. Clin Cancer Res. 2002 Sep;8(9):2902-11.
t(11;14)(q13;q32.     Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood. 1994 Oct 1;84(7):2283-90.
t(11;14)(q13;q32)     Localization of 11q13 loci with respect to regional chromosomal breakpoints. Genomics. 1992 Apr;12(4):738-44.
t(11;14)(q13;q32)     Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model. Cancer Genet Cytogenet. 2003 May;143(1):32-8.
t(11;14)(q13;q32)     Multicolor spectral karyotyping identifies new recurring breakpoints and translocations in multiple myeloma. Blood. 1998 Sep 1;92(5):1743-8.
t(11;14)(q13;q32)     Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14). Am J Pathol. 2000 May;156(5):1505-13.
t(11;14)(q13;q32)     Comment in: Blood. 2003 Feb 15;101(4):1653. Blood. 2002 Aug 15;100(4):1417-24.
t(11;14)(q13;q32)     Cyclin D1 protein expression in mantle cell lymphoma. Ann Oncol. 1995 Jul;6(6):567-70.
t(11;14)(q13;q32)     Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas. Am J Pathol. 1998 Dec;153(6):1969-76.
t(11;14)(q13;q32)     Comment in: Blood. 1997 Jan 1;89(1):349-50. Blood. 1996 Jul 15;88(2):674-81.
t(11;14)(q13;q32)     A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus in a t(8;12)(q24;q22) translocation in a case of B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer. 1991 Jan;3(1):24-36.
t(11;14)(q13;q32)     Molecular analysis of 11q13 breakpoints in multiple myeloma. Blood. 1999 Feb 15;93(4):1330-7.
t(11;14)(q13;q32)     Chromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group. Blood. 1990 May 1;75(9):1841-7.
t(11;14)(q13;q32)     [Recent advances in molecular cytogenetics of leukemia] Rinsho Ketsueki. 1993 Mar;34(3):251-9.
t(11;14)(q13;q32)     Lymphomatous polyp of mantle cell type in the duodenum complicated by gastric cancer: a case of trisomy 3 and t(11;14)(q13;q32). Ann Hematol. 2002 Apr;81(4):224-7. Epub 2002 Feb 28.

Copyright © 2002-2004 Chang Bioscience, Inc. All rights reserved.